Evidence map›Paper›PMID 28746263›Full record

ArticleThe Pediatric infectious disease journal2017

Treatment Outcomes of Children With HIV Infection and Drug-resistant TB in Three Provinces in South Africa, 2005-2008.

Eric W Hall, Sapna B Morris, Brittany K Moore, Linda Erasmus, Ronel Odendaal, Heather Menzies, Martie van der Walt, Sarah E Smith

Open access · greenAbstract read
In one paragraph

Article in The Pediatric infectious disease journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 5 pooled it
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 5 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Eric W HallFrom the *Department of Epidemiology, Emory University, Atlanta, Georgia; †U.S. Centers for Disease Control and Prevention, Atlanta, Georgia; ‡National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa; and §South African Medical Research Council, Pretoria, South Africa.
Sapna B Morris
Brittany K Moore
Linda Erasmus
Ronel Odendaal
Heather Menzies
Martie van der Walt
Sarah E Smith
Centers for Disease Control and Prevention · USSouth African Medical Research Council · ZAEmory University · USNational Health Laboratory Service · ZA

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

objectiveTo describe outcomes of HIV-infected pediatric patients with drug-resistant tuberculosis (DR TB).

methodsDemographic, clinical and laboratory data from charts of pediatric patients treated for DR TB during 2005-2008 were collected retrospectively from 5 multi-DR TB hospitals in South Africa. Data were summarized, and Pearson χ test or Fisher exact test was used to assess differences in variables of interest by HIV status. A time-to-event analysis was conducted using days from start of treatment to death. Variables of interest were first assessed using the Kaplan-Meier method. Cox proportional hazard models were fit to estimate crude and adjusted hazard ratios.

resultsOf 423 eligible participants, 398 (95%) had culture-confirmed DR TB and 238 (56%) were HIV infected. A total of 54% were underweight, 42% were male and median age was 10.7 years (interquartile range: 5.5-15.3). Of the 423 participants, 245 (58%) were successfully treated, 69 (16%) died, treatment failed in 3 (1%), 36 (9%) were lost to follow-up and 70 (17%) were still on treatment, transferred or had unknown outcomes. Time to death differed by HIV status (P = 0.008), sex (P < 0.001), year of tuberculosis diagnosis (P = 0.05) and weight status (P = 0.002). Over the 2-year risk period, the adjusted rate of death was 2-fold higher among participants with HIV compared with HIV-negative participants (adjusted hazard ratio = 2.28; 95% confidence interval: 1.11-4.68).

conclusionsMale, underweight and HIV-infected children with DR TB were more likely to experience death when compared with other children with DR TB within this study population.

Indexed as

HIV InfectionsTuberculosis, Multidrug-ResistantAdolescentAnti-HIV AgentsAntitubercular AgentsChildChild, PreschoolCoinfectionFemaleHumansInfantInfant, NewbornKaplan-Meier EstimateMaleRetrospective StudiesSouth AfricaAnti-HIV AgentsAntitubercular Agents

Identifiers

PMID28746263
PMCPMC5797992
OpenAlexW2737059253

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.